Kyu-Jae Lee

Dr. Kyu-Jae Lee

Department of Environmental Medical Biology, Wonju College of Medicine, Yonsei University, Korea
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2022 in Processes
Verified
Journal Article
Open access
PDF file
SLSeul-Yi Lee
Seul-Yi Lee
JLJong-Hoon Lee
Jong-Hoon Lee
YKYeong-Hun Kim
Yeong-Hun Kim
JKJong-Woo Kim
Jong-Woo Kim
Kyu-Jae LeeKyu-Jae Lee
Kyu-Jae Lee
SPSoo-Jin Park
Soo-Jin Park
With the rapid growth in demand for effective and renewable energy, the hydrogen era has begun. To meet commercial requirements, efficient hydrogen storage techniques are required. So far, four techniques have been suggested for hydrogen storage: compressed storage, hydrogen liquefaction, chemical absorption, and physical adsorption. Currently, high-pressure compressed tanks are used in the industry; however, certain limitations such as high costs, safety concerns, undesirable amounts of occupied space, and low storage capacities are still challenges. Physical hydrogen adsorption is one of the most promising techniques; it uses porous adsorbents, which have material benefits such as low costs, high storage densities, and fast charging–discharging kinetics. During adsorption on material surfaces, hydrogen molecules weakly adsorb at the surface of adsorbents via long-range dispersion forces. The largest challenge in the hydrogen era is the development of progressive materials for efficient hydrogen storage. In designing efficient adsorbents, understanding interfacial interactions between hydrogen molecules and porous material surfaces is important. In this review, we briefly summarize a hydrogen storage technique based on US DOE classifications and examine hydrogen storage targets for feasible commercialization. We also address recent trends in the development of hydrogen storage materials. Lastly, we propose spillover mechanisms for efficient hydrogen storage using solid-state adsorbents.

2 September 2021 in Molecules
Verified
Journal Article
Open access
PDF file
HRHabibur Rahman
Habibur Rahman
JBJohny Bajgai
Johny Bajgai
AFAILYN FEDELIN FADRIQUELA
AILYN FEDELIN FADRIQUELA
SSSubham Sharma
Subham Sharma
TTThuy Trinh Thi
Thuy Trinh Thi
Kyu-Jae LeeKyu-Jae Lee
Kyu-Jae Lee
Natural products derived from plants, as well as their bioactive compounds, have been extensively studied in recent years for their therapeutic potential in a variety of neurodegenerative diseases (NDs), including Alzheimer’s (AD), Huntington’s (HD), and Parkinson’s (PD) disease. These diseases are characterized by progressive dysfunction and loss of neuronal structure and function. There has been little progress in designing efficient treatments, despite impressive breakthroughs in our understanding of NDs. In the prevention and therapy of NDs, the use of natural products may provide great potential opportunities; however, many clinical issues have emerged regarding their use, primarily based on the lack of scientific support or proof of their effectiveness and patient safety. Since neurodegeneration is associated with a myriad of pathological processes, targeting multi-mechanisms of action and neuroprotection approaches that include preventing cell death and restoring the function of damaged neurons should be employed. In the treatment of NDs, including AD and PD, natural products have emerged as potential neuroprotective agents. This current review will highlight the therapeutic potential of numerous natural products and their bioactive compounds thatexert neuroprotective effects on the pathologies of NDs.

26 May 2009 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
XQXu‐Feng Qi
Xu‐Feng Qi
DKDong‐Heui Kim
Dong‐Heui Kim
YYYang‐Suk Yoon
Yang‐Suk Yoon
DJDan Jin
Dan Jin
XHXue‐Zhu Huang
Xue‐Zhu Huang
Kyu-Jae LeeKyu-Jae Lee
Kyu-Jae Lee

12 December 2018 in Catalysts
Verified
Journal Article
Open access
PDF file
YZYifan Zhang
Yifan Zhang
YHYoung-Jung Heo
Young-Jung Heo
JLJi-Won Lee
Ji-Won Lee
JLJong-Hoon Lee
Jong-Hoon Lee
JBJohny Bajgai
Johny Bajgai
SPSoo-Jin Park
Soo-Jin Park
Photocatalytic H2 generation via water splitting is increasingly gaining attention as a viable alternative for improving the performance of H2 production for solar energy conversion. Many methods were developed to enhance photocatalyst efficiency, primarily by modifying its morphology, crystallization, and electrical properties. Here, we summarize recent achievements in the synthesis and application of various photocatalysts. The rational design of novel photocatalysts was achieved using various strategies, and the applications of novel materials for H2 production are displayed herein. Meanwhile, the challenges and prospects for the future development of H2-producing photocatalysts are also summarized.

6 February 2021 in Processes
Verified
Journal Article
Open access
PDF file
HRHabibur Rahman
Habibur Rahman
JBJohny Bajgai
Johny Bajgai
AFAILYN FEDELIN FADRIQUELA
AILYN FEDELIN FADRIQUELA
SSSubham Sharma
Subham Sharma
TTThuy Trinh Thi
Thuy Trinh Thi
Kyu-Jae LeeKyu-Jae Lee
Kyu-Jae Lee
Oxidative stress (OS) and neuroinflammatory stress affect many neurological disorders. Despite the clinical significance of oxidative damage in neurological disorders, still, no effective and safe treatment methods for neuro diseases are available. With this, molecular hydrogen (H2) has been recently reported as an antioxidant and anti-inflammatory agent to treat several oxidative stress-related diseases. In animal and human clinical trials, the routes for H2 administration are mainly categorized into three types: H2 gas inhalation, H2 water dissolving, and H2-dissolved saline injection. This review explores some significant progress in research on H2 use in neurodegenerative diseases (NDs), including Alzheimer’s disease, Parkinson’s disease, neonatal disorders of the brain, and other NDs (retinal ischemia and traumatic brain injury). Even though most neurological problems are not currently curable, these studies have shown the therapeutic potential for prevention, treatment, and mitigation of H2 administration. Several possible H2-effectors, including cell signaling molecules and hormones, which prevent OS and inflammation, will also be addressed. However, more clinical and other related studies are required to evaluate the direct H2 target molecule.

29 September 2010 in Toxicology Letters
Verified
Journal Article
Closed access
XQXu-Feng Qi
Xu-Feng Qi
DKDong-Heui Kim
Dong-Heui Kim
YYYang-Suk Yoon
Yang-Suk Yoon
SKSoo-Ki Kim
Soo-Ki Kim
DCDong-Qing Cai
Dong-Qing Cai
Kyu-Jae LeeKyu-Jae Lee
Kyu-Jae Lee